Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Whitehawk Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- +15 vs. Q4 2025
- Shares held
- 34.2M
- +2.86M (+9.1%) vs. Q4 2025
- Total value
- $118.2M
- +$42.8M (+56.7%) vs. Q4 2025
- New holders
- 21
- 15 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 8 | $28 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 23 | $79 | 0.00% | +4+21.1% | Added |
| CWM, LLC | 25 | $86 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 121 | $397 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 202 | $697 | 0.00% | +42+26.3% | Added |
| TD Waterhouse Canada Inc. | 232 | $814 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 177 | $1.00K | 0.00% | +177 | New |
| Russell Investments Group, Ltd. | 386 | $1.33K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 647 | $2.23K | 0.00% | +647 | New |
| Bartlett & Co. Wealth Management LLC | 1,333 | $5.54K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,639 | $5.65K | 0.00% | −1,431−46.6% | Reduced |
| US Bancorp | 3,333 | $11.5K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 6,159 | $21.2K | 0.00% | +6,159 | New |
| Morgan Stanley | 8,342 | $28.8K | 0.00% | +1,594+23.6% | Added |
| Prelude Capital Management, LLC | 10,283 | $35.5K | 0.00% | −8,513−45.3% | Reduced |
| UBS Group AG | 11,438 | $39.5K | 0.00% | −18,406−61.7% | Reduced |
| Omers Administration Corp | 11,500 | $39.7K | 0.00% | +11,500 | New |
| Brevan Howard Capital Management LP | 12,589 | $43.4K | 0.00% | +12,589 | New |
| Vanguard Global Advisers, LLC | 20,177 | $69.6K | 0.00% | +20,177 | New |
| XTX Topco Ltd | 22,983 | $79.3K | 0.00% | +7,279+46.4% | Added |
| Occudo Quantitative Strategies LP | 22,291 | $89.4K | 0.00% | +22,291 | New |
| Catalyst Funds Management Pty Ltd | 27,011 | $93.2K | 0.02% | +27,011 | New |
| Point72 Asset Management, L.P. | 28,026 | $96.7K | 0.00% | +28,026 | New |
| Dimensional Fund Advisors LP | 30,090 | $103.8K | 0.00% | +1,449+5.1% | Added |
| Bailard, Inc. | 31,398 | $108.3K | 0.00% | +31,398 | New |
| HRT Financial LP | 34,935 | $120.0K | 0.00% | +34,935 | New |
| Qube Research & Technologies Ltd | 48,307 | $166.7K | 0.00% | −24,041−33.2% | Reduced |
| Bank of America Corp | 52,861 | $182.4K | 0.00% | +52,450+12,761.6% | Added |
| Seven Fleet Capital Management LP | 54,296 | $187.3K | 0.06% | +54,296 | New |
| Goldman Sachs Group Inc | 56,912 | $196.3K | 0.00% | +56,912 | New |
| Hudson Bay Capital Management LP | 57,597 | $198.7K | 0.00% | +57,597 | New |
| Acadian Asset Management LLC | 70,101 | $239.0K | 0.00% | +45,467+184.6% | Added |
| Citadel Advisors LLC | 91,852 | $316.9K | 0.00% | −7,098−7.2% | Reduced |
| Northern Trust Corp | 107,266 | $370.1K | 0.00% | +3,814+3.7% | Added |
| Verdad Advisers, LP | 115,484 | $398.4K | 0.45% | +115,484 | New |
| ADAR1 Capital Management, LLC | 128,503 | $443.3K | 0.03% | +50,910+65.6% | Added |
| Jane Street Group, LLC | 151,110 | $521.3K | 0.00% | +81,179+116.1% | Added |
| State Street Corp | 160,382 | $553.3K | 0.00% | +14,845+10.2% | Added |
| Susquehanna International Group, LLP | 203,465 | $702.0K | 0.00% | +93,382+84.8% | Added |
| Vanguard Fiduciary Trust Co | 214,827 | $741.2K | 0.00% | +214,827 | New |
| Bridgeway Capital Management, LLC | 215,284 | $742.7K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 273,482 | $943.5K | 0.00% | −36,383−11.7% | Reduced |
| Woodline Partners LP | 281,497 | $971.2K | 0.00% | +281,497 | New |
| Eversept Partners, LP | 306,800 | $1.06M | 0.07% | +46,541+17.9% | Added |
| Millennium Management LLC | 309,674 | $1.07M | 0.00% | +309,674 | New |
| BlackRock, Inc. | 351,385 | $1.21M | 0.00% | +52,374+17.5% | Added |
| Renaissance Technologies LLC | 428,622 | $1.48M | 0.00% | −12,100−2.7% | Reduced |
| Geode Capital Management, LLC | 457,540 | $1.58M | 0.00% | +32,100+7.5% | Added |
| Balyasny Asset Management LLC | 550,441 | $1.90M | 0.00% | +550,441 | New |
| Ally Bridge Group (NY) LLC | 817,939 | $2.82M | 2.80% | 00.0% | Unchanged |
| StemPoint Capital LP | 939,369 | $3.24M | 0.62% | −519,438−35.6% | Reduced |
| Acorn Capital Advisors, LLC | 1,139,363 | $3.93M | 1.12% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 1,315,770 | $4.54M | 0.00% | +1,315,770 | New |
| Fan Yu | 2,070,000 | $7.14M | 7.36% | 00.0% | Unchanged |
| Siren, L.L.C. | 2,082,000 | $7.18M | 0.20% | 00.0% | Unchanged |
| KVP Capital Advisors, LP | 2,165,997 | $7.47M | 5.58% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 2,849,402 | $9.83M | 0.10% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 3,410,402 | $11.8M | 8.37% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,700,000 | $12.8M | 0.35% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,166,000 | $14.4M | 0.33% | 00.0% | Unchanged |
| QVT Financial LP | 4,615,709 | $15.9M | 1.26% | 00.0% | Unchanged |
| Ames National Corp | 4,571 | – | – | +4,571 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −67,959−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −42,400−100.0% | Sold out |
| ABG Innovation Capital Partners III GP Ltd | 0 | $0 | 0.00% | −26,666−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −11,447−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −1,254−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |